Venous thromboembolism following hematopoietic stem cell transplantation—a systematic review and meta-analysis

NIH Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. The 2014 Pathology Working Group Report

(2015) Howard M. Shulman et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Endothelial Dysfunction and Altered Mechanical and Structural Properties of Resistance Arteries in a Murine Model of Graft-versus-Host Disease

(2014) Peter M. Schmid et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2013) David Moher   ANNALS OF INTERNAL MEDICINE

Epidemiology of cancer-associated venous thrombosis

(2013) J. F. Timp et al.   BLOOD

Incidence of and risk factors for persistent gram-positive bacteraemia and catheter-related thrombosis in haematopoietic stem cell transplantation

(2013) A Richters et al.   BONE MARROW TRANSPLANTATION

Male survivors of allogeneic hematopoietic stem cell transplantation have a long term persisting risk of cardiovascular events

(2013) Priyanka A. Pophali et al.   EXPERIMENTAL HEMATOLOGY

Analysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipients

(2012) J. Labrador et al.   HAEMATOLOGICA

Sirolimus and mycophenolate mofetil as GVHD prophylaxis in myeloablative, matched-related donor hematopoietic cell transplantation

(2011) L Johnston et al.   BONE MARROW TRANSPLANTATION

Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial

(2011) Amrita Krishnan et al.   LANCET ONCOLOGY

Endothelial Dysfunction after Hematopoietic Stem Cell Transplantation: Role of the Conditioning Regimen and the Type of Transplantation

(2010) Marta Palomo et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Rapid improvement of life-threatening capillary leak syndrome after stem cell transplantation by bevacizumab

(2010) H. Yabe et al.   BLOOD

Lower leukemia relapse in pediatric patients with pulmonary cytolytic thrombi following allogeneic transplant

(2010) A R Smith et al.   BONE MARROW TRANSPLANTATION

A Phase I/II Trial Combining High-Dose Melphalan and Autologous Transplant with Bortezomib for Multiple Myeloma: A Dose- and Schedule-Finding Study

(2010) S. Lonial et al.   CLINICAL CANCER RESEARCH

Thrombotic complications after haematopoietic stem cell transplantation: early and late effects

(2009) Dimitrios A. Tsakiris et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

Vascular endothelium as ‘novel’ target of graft-versus-host disease

(2008) André Tichelli et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

Transplantation from Matched Siblings Using Once-Daily Intravenous Busulfan/Fludarabine with Thymoglobulin: A Myeloablative Regimen with Low Nonrelapse Mortality in All But Older Patients with High-Risk Disease

(2008) James A. Russell et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab

(2008) I. F. Khouri et al.   BLOOD

The incidence of and risk factors for venous thromboembolism (VTE) and bleeding among 1514 patients undergoing hematopoietic stem cell transplantation: implications for VTE prevention

(2008) D. E. Gerber et al.   BLOOD

Development and validation of a predictive model for chemotherapy-associated thrombosis

(2008) A. A. Khorana et al.   BLOOD

Incidence of symptomatic venous thromboembolism following hematopoietic stem cell transplantation

(2008) A. GONSALVES et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS